Endpoints News· Elizabeth Cairns·· 20 小时前AI 评分18
Gubra 谋求拓展代谢领域之外管线，冀望今年迎来首家投资组合公司
Gubra looks beyond metabolism, hopes for first portfolio company this year
AI 导读
总部位于哥本哈根的 Gubra 目前业务以肥胖症为主，未来需依靠更广泛的管线。公司已建立投资组合，并希望今年内落地首家投资组合公司。
正文 · 原文
The Copenhagen-based drugmaker Gubra’s present is mostly about obesity. Its future will need to be about a much broader pipeline.
The company has a portfolio …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源：Endpoints News · endpoints.news